SCHEMBL24254555

SCHEMBL24254555

CCc1ccc(SCl)cc1NC(C)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 2/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 1/20 0.37
GAA P10253 1/20 0.37
ALDH1A1 P00352 5/20 0.37
ESR1 P03372 1/20 0.37
HPGD P15428 2/20 0.36
KMT2A Q03164 1/20 0.36
LMNA P02545 1/20 0.35
PGK1 P00558 1/20 0.35
NR4A1 P22736 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24254554 0.81 TSHR (0.39) MAPK1MAPTPOLBRAB9ANPC1
SCHEMBL23524965 0.78 KDM4E (0.56) MAPTPOLBRAB9AKDM4EHSD17B10
SCHEMBL9352526 0.78 ALDH1A1 (0.47) MAPK1MAPTPOLBRAB9ANPC1
SCHEMBL1976549 0.73 ALDH1A1 (0.51) MAPK1MAPTPOLBNPC1KDM4E
SCHEMBL18409424 0.72 KMT2A (0.43) MAPK1MAPTPOLBRAB9ANPC1
SCHEMBL12329332 0.72 HTT (0.52) MAPK1MAPTKDM4ETSHRGAA
SCHEMBL24254558 0.72 ALDH1A1 (0.51) POLBALDH1A1KMT2ACYP1A2CYP2C9
SCHEMBL12594066 0.71 ALDH1A1 (0.49) MAPTPOLBRAB9ANPC1KDM4E
SCHEMBL17681596 0.71 ALDH1A1 (0.65) MAPTRAB9ANPC1KDM4EHSD17B10
SCHEMBL14204703 0.71 ALDH1A1 (0.40) MAPK1MAPTPOLBRAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed